Add Presentation to Slide Tray Presentation:
Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care
Authors: Martha P. Mims, M.D., Ph.D.
Evidence of rFVIIa Use for Bleeding Secondary to Brain Trauma vs. Usual Care
There was one RCT (fair quality) and one comparative observational study (fair quality) with a total of 79 patients who received rFVIIa.
- Yank V, Tuohy CV, Logan AC, et al. Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care, Comparative Effectiveness Review 21 (Prepared by Stanford–UCSF Evidence-based Practice Center under Contract No. 290-02-0017). Rockville, MD: Agency for Healthcare Research and Quality; May 2010. AHRQ Publication No. 10-EHC030-EF.
Your slide tray is being processed.